No Data
No Data
No Data
No Data
No Data
BioCardia Completes Enrollment Of CardiAMP Cell Therapy For Treatment Of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
BioCardia Completes Enrollment Of CardiAMP Cell Therapy For Treatment Of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
BenzingaApr 25 21:01
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders in
BenzingaApr 22 19:38
BioCardia(BCDA.US) Officer Buys US$1,012.83 in Common Stock
$BioCardia(BCDA.US)$ Officer Altman Peter purchased 2,750 shares of common stock on Apr 19, 2024 at an average price of $0.3683 for a total value of $1,012.83.Source: Announcement What is statement of
Futu NewsApr 20 06:19
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO
BenzingaMar 29 20:06
BioCardia Full Year 2023 Earnings: Misses Expectations
Yahoo FinanceMar 29 18:11
BioCardia(BCDA.US) Officer Buys US$195 in Common Stock
$BioCardia(BCDA.US)$ Officer Altman Peter purchased 500 shares of Common Stock on Mar 28, 2024 at an average price of $0.39 for a total value of $195.Source: Announcement What is statement of changes
Futu NewsMar 29 08:14
No Data
No Data